{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-011911","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.177730+00:00","generated_at":"2026-05-17T07:33:53.428099+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Coherus Oncology regains Nasdaq compliance after bid price shortfall","bullets":["On June 30, 2025, Coherus received a Nasdaq deficiency notice for bid price below $1.00 for 30 consecutive business days.","Company had 180 days, until December 29, 2025, to regain compliance.","On September 5, 2025, Nasdaq confirmed Coherus's closing price was $1.00 or greater for the requisite period.","Company is now in full compliance with all Nasdaq continued listing standards; matter is closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-011911","json":"https://secwatch.observer/filing/0001558370-25-011911.json","markdown":"https://secwatch.observer/filing/0001558370-25-011911.md","text":"https://secwatch.observer/filing/0001558370-25-011911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000155837025011911/0001558370-25-011911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000155837025011911/chrs-20250905x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:33:53.428099+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}